Susquehanna International Group’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-457,722
| Closed | -$346K | – | 6333 |
|
|
2025
Q1 | $346K | Sell |
457,722
-19,953
| -4% | -$15.1K | ﹤0.01% | 4831 |
|
|
2024
Q4 | $460K | Buy |
477,675
+113,333
| +31% | +$109K | ﹤0.01% | 4197 |
|
|
2024
Q3 | $525K | Buy |
364,342
+102,446
| +39% | +$148K | ﹤0.01% | 3591 |
|
|
2024
Q2 | $317K | Buy |
261,896
+242,990
| +1,285% | +$294K | ﹤0.01% | 4138 |
|
|
2024
Q1 | $44.4K | Sell |
18,906
-15,438
| -45% | -$36.3K | ﹤0.01% | 5190 |
|
|
2023
Q4 | $64.9K | Buy |
34,344
+21,850
| +175% | +$41.3K | ﹤0.01% | 5485 |
|
|
2023
Q3 | $17.1K | Sell |
12,494
-30,306
| -71% | -$41.5K | ﹤0.01% | 5288 |
|
|
2023
Q2 | $104K | Sell |
42,800
-69,304
| -62% | -$168K | ﹤0.01% | 4992 |
|
|
2023
Q1 | $646K | Buy |
112,104
+93,573
| +505% | +$539K | ﹤0.01% | 3491 |
|
|
2022
Q4 | $166K | Sell |
18,531
-45,469
| -71% | -$406K | ﹤0.01% | 4623 |
|
|
2022
Q3 | $910K | Buy |
64,000
+53,095
| +487% | +$755K | ﹤0.01% | 2664 |
|
|
2022
Q2 | $159K | Buy |
+10,905
| New | +$159K | ﹤0.01% | 4731 |
|
|
2022
Q1 | – | Sell |
-41,216
| Closed | -$721K | – | 5667 |
|
|
2021
Q4 | $721K | Buy |
+41,216
| New | +$721K | ﹤0.01% | 3292 |
|
|
2021
Q3 | – | Sell |
-19,563
| Closed | -$201K | – | 5274 |
|
|
2021
Q2 | $201K | Sell |
19,563
-66,729
| -77% | -$686K | ﹤0.01% | 4834 |
|
|
2021
Q1 | $1.13M | Buy |
86,292
+61,307
| +245% | +$802K | ﹤0.01% | 2835 |
|
|
2020
Q4 | $351K | Buy |
+24,985
| New | +$351K | ﹤0.01% | 3742 |
|
|
2020
Q3 | – | Sell |
-2,390
| Closed | -$36K | – | 4368 |
|
|
2020
Q2 | $36K | Sell |
2,390
-5,436
| -69% | -$81.9K | ﹤0.01% | 4070 |
|
|
2020
Q1 | $56K | Buy |
7,826
+1,807
| +30% | +$12.9K | ﹤0.01% | 4178 |
|
|
2019
Q4 | $63K | Buy |
+6,019
| New | +$63K | ﹤0.01% | 3745 |
|